Added to YB: 2025-04-15
Pitch date: 2025-04-13
COLO-B.CO [neutral]
Coloplast A/S
-17.59%
current return
Author Info
Disruptive Analytics has 30+ years of experience as a retail investor and is now fully engaged in managing their own money. Sign up for the newsletter.
Company Info
Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally.
Market Cap
DKK 141.5B
Pitch Price
DKK 680.46
Price Target
N/A
Dividend
3.50%
EV/EBITDA
18.74
P/E
34.78
EV/Sales
5.92
Sector
Health Care Equipment and Supplies
Category
growth
Medical Devices - Coloplast A/S
COLO-B.CO (overview): Danish medical device co. for intimate healthcare. 3.3% div yield, DKK 157B mkt cap. Strive25 strategy: 8-10% organic rev growth, 30%+ EBIT margin post-2024/25. New products driving growth. Acquisitions in key areas. Global expansion. 8% organic growth achieved, EBIT margin at 27-28%. Analysts expect 30%+ EBIT by 2028.
Read full article (1 min)